Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both Worlds

Published:2019-06 Issue: Volume:13 Page:93-106
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Sivanandam Venkatesh,LaRocca Christopher J.,Chen Nanhai G.,Fong Yuman,Warner Susanne G.

Funder

Susan E. Riley Foundation

American Cancer Society Mentored Research Scholar

Hope Portfolio Fund of the City of Hope

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference120 articles.

1. A million Africans a year dying from cancer by 2030: what can cancer research and control offer to the continent? Int.;Sylla;J. Cancer,2012

2. Immunotherapy for pancreatic cancer: Barriers and breakthroughs;Torphy;Ann. Gastroenterol. Surg.,2018

3. Converting Cold into Hot Tumors by Combining Immunotherapies;Haanen;Cell,2017

4. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer;Brahmer;N. Engl. J. Med.,2012

5. Oncolytic virotherapy;Russell;Nat. Biotechnol.,2012

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer;Pharmaceutics;2024-09-07

2. Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-09

3. Neuroblastoma—A Review of Combination Immunotherapy;International Journal of Molecular Sciences;2024-07-15

4. The investigation of oncolytic viruses in the field of cancer therapy;Frontiers in Oncology;2024-07-10

5. Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer;Molecular Therapy: Oncology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3